SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Wockhardt incorporates new subsidiary

05 Jul 2021 Evaluate

Wockhardt has incorporated a new subsidiary namely Wockhardt Biologics under the provisions of the Companies Act, 2013 on July 2, 2021. The Authorised, subscribed and paid-up capital of the Wockhardt Biologics is Rs 5,00,000 divided into 50,000 equity shares of Rs 10 each out of which Wockhardt will hold approximately 65% of the total share capital while the remaining stake will be held by certain Promoter Group/ Group entities.

Wockhardt is a research based global pharmaceutical and Biotech Company headquartered in Mumbai, India.

Wockhardt Share Price

1963.65 -4.25 (-0.22%)
25-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1862.15
Dr. Reddys Labs. 1350.00
Cipla 1440.30
Zydus Lifesciences 1101.50
Lupin 2342.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: